Two copies of APOE4 can raise Alzheimer's risk up to 15-fold, yet it is still not destiny — roughly half of Alzheimer's patients carry no APOE4 at all. Knowing your status can sharpen risk factor management and inform long-term planning, but it doesn't yet map onto established preventive interventions.